Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

The effect of ranitidine on olanzapine-induced weight gain.

Ranjbar F, Ghanepour A, Sadeghi-Bazargani H, Asadlo M, Alizadeh A.

Biomed Res Int. 2013;2013:639391. doi: 10.1155/2013/639391. Epub 2013 Jul 30.

2.

Efficacy of ranitidine in olanzapine-induced weight gain: a dose-response study.

Mehta VS, Ram D.

Early Interv Psychiatry. 2016 Dec;10(6):522-527. doi: 10.1111/eip.12205. Epub 2014 Dec 21.

PMID:
25529756
3.

Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.

Wu RR, Zhao JP, Guo XF, He YQ, Fang MS, Guo WB, Chen JD, Li LH.

Am J Psychiatry. 2008 Mar;165(3):352-8. doi: 10.1176/appi.ajp.2007.07010079. Epub 2008 Feb 1.

PMID:
18245179
4.

A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.

Henderson DC, Copeland PM, Daley TB, Borba CP, Cather C, Nguyen DD, Louie PM, Evins AE, Freudenreich O, Hayden D, Goff DC.

Am J Psychiatry. 2005 May;162(5):954-62.

PMID:
15863798
5.

Weight gain during treatment of bipolar I patients with olanzapine.

Hennen J, Perlis RH, Sachs G, Tohen M, Baldessarini RJ.

J Clin Psychiatry. 2004 Dec;65(12):1679-87.

PMID:
15641874
6.

The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study.

Poyurovsky M, Tal V, Maayan R, Gil-Ad I, Fuchs C, Weizman A.

Eur Neuropsychopharmacol. 2004 Aug;14(4):332-6.

PMID:
15163444
7.

[Randomized, open label study on the use of ranitidine at different doses for the management of weight gain associated with olanzapine administration].

López-Mato A, Rovner J, Illa G, Vieitez A, Boullosa O.

Vertex. 2003 Jun-Aug;14(52):85-96. Spanish.

PMID:
12883589
8.

Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine.

Assunção SS, Ruschel SI, Rosa Lde C, Campos JA, Alves MJ, Bracco OL, de Lima MS.

Rev Bras Psiquiatr. 2006 Dec;28(4):270-6. Erratum in: Rev Bras Psiquiatr. 2007 Mar;29(1):v.

9.

Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder.

Lipkovich I, Jacobson JG, Hardy TA, Hoffmann VP.

BMC Psychiatry. 2008 Sep 15;8:78. doi: 10.1186/1471-244X-8-78.

10.

Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial.

Kwon JS, Choi JS, Bahk WM, Yoon Kim C, Hyung Kim C, Chul Shin Y, Park BJ, Geun Oh C.

J Clin Psychiatry. 2006 Apr;67(4):547-53.

PMID:
16669719
11.

Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study.

Poyurovsky M, Isaacs I, Fuchs C, Schneidman M, Faragian S, Weizman R, Weizman A.

Am J Psychiatry. 2003 Feb;160(2):297-302.

PMID:
12562576
12.

Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial.

Narula PK, Rehan HS, Unni KE, Gupta N.

Schizophr Res. 2010 May;118(1-3):218-23. doi: 10.1016/j.schres.2010.02.001. Epub 2010 Mar 7.

PMID:
20207521
13.

Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.

Baptista T, Martínez J, Lacruz A, Rangel N, Beaulieu S, Serrano A, Arapé Y, Martinez M, de Mendoza S, Teneud L, Hernández L.

Can J Psychiatry. 2006 Mar;51(3):192-6.

PMID:
16618011
14.

A Naturalistic Randomized Placebo-Controlled Trial of Extended-Release Metformin to Prevent Weight Gain Associated With Olanzapine in a US Community-Dwelling Population.

Rado J, von Ammon Cavanaugh S.

J Clin Psychopharmacol. 2016 Apr;36(2):163-8. doi: 10.1097/JCP.0000000000000469.

PMID:
26872112
15.

An exploration of the effect of modafinil on olanzapine associated weight gain in normal human subjects.

Roerig JL, Steffen KJ, Mitchell JE, Crosby RD, Gosnell BA.

Biol Psychiatry. 2009 Apr 1;65(7):607-13. doi: 10.1016/j.biopsych.2008.10.037. Epub 2008 Dec 21.

PMID:
19103435
16.

Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever.

Kluge M, Schuld A, Schacht A, Himmerich H, Dalal MA, Wehmeier PM, Hinze-Selch D, Kraus T, Dittmann RW, Pollmächer T.

Psychoneuroendocrinology. 2009 Jan;34(1):118-28. doi: 10.1016/j.psyneuen.2008.08.016. Epub 2008 Oct 4.

PMID:
18835660
17.

Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder.

Stauffer VL, Sniadecki JL, Piezer KW, Gatz J, Kollack-Walker S, Hoffmann VP, Conley R, Durell T.

BMC Psychiatry. 2010 Nov 3;10:89. doi: 10.1186/1471-244X-10-89.

18.

Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.

Ujike H, Nomura A, Morita Y, Morio A, Okahisa Y, Kotaka T, Kodama M, Ishihara T, Kuroda S.

J Clin Psychiatry. 2008 Sep;69(9):1416-22.

PMID:
19193342
19.

A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.

McQuade RD, Stock E, Marcus R, Jody D, Gharbia NA, Vanveggel S, Archibald D, Carson WH.

J Clin Psychiatry. 2004;65 Suppl 18:47-56.

PMID:
15600384
20.

Supplemental Content

Support Center